ES2256232T3 - Metodos y composiciones para provocar una respuesta inmunitaria. - Google Patents

Metodos y composiciones para provocar una respuesta inmunitaria.

Info

Publication number
ES2256232T3
ES2256232T3 ES01930632T ES01930632T ES2256232T3 ES 2256232 T3 ES2256232 T3 ES 2256232T3 ES 01930632 T ES01930632 T ES 01930632T ES 01930632 T ES01930632 T ES 01930632T ES 2256232 T3 ES2256232 T3 ES 2256232T3
Authority
ES
Spain
Prior art keywords
chemotaxin
cells
apc
chemokine
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01930632T
Other languages
English (en)
Spanish (es)
Inventor
Thomas J. Schall
Dale Talbot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemocentryx Inc
Original Assignee
Chemocentryx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemocentryx Inc filed Critical Chemocentryx Inc
Application granted granted Critical
Publication of ES2256232T3 publication Critical patent/ES2256232T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
ES01930632T 2000-04-21 2001-04-20 Metodos y composiciones para provocar una respuesta inmunitaria. Expired - Lifetime ES2256232T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19883900P 2000-04-21 2000-04-21
US198839P 2000-04-21
US83481401A 2001-04-12 2001-04-12
US834814 2001-04-12

Publications (1)

Publication Number Publication Date
ES2256232T3 true ES2256232T3 (es) 2006-07-16

Family

ID=26894197

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01930632T Expired - Lifetime ES2256232T3 (es) 2000-04-21 2001-04-20 Metodos y composiciones para provocar una respuesta inmunitaria.

Country Status (9)

Country Link
EP (1) EP1274454B1 (https=)
JP (1) JP4903342B2 (https=)
AT (1) ATE314088T1 (https=)
AU (2) AU5714801A (https=)
CA (1) CA2406853C (https=)
DE (1) DE60116280T2 (https=)
DK (1) DK1274454T3 (https=)
ES (1) ES2256232T3 (https=)
WO (1) WO2001080882A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361329B2 (en) 2000-04-21 2008-04-22 Chemocentryx, Inc. Compositions for inducing an immune response
WO2003035106A1 (en) * 2001-10-24 2003-05-01 Chemocentryx Methods and compositions for inducing an immune response by co-administering a chemokine with an antigen
ES2453592T3 (es) 2007-08-02 2014-04-08 Novimmune Sa Anticuerpos anti-RANTES y métodos de uso de los mismos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840637D1 (de) * 1997-12-11 2009-04-16 Univ Maryland Biotech Inst Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
ATE512231T1 (de) * 1998-02-27 2011-06-15 Univ Pennsylvania Impfstoffe, immuntherapeutika und verfahren zur anwendung derselben
JP2002512013A (ja) * 1998-04-22 2002-04-23 カイロン コーポレイション ケモカインを使用することによる遺伝的免疫に対する免疫応答の増強

Also Published As

Publication number Publication date
AU5714801A (en) 2001-11-07
WO2001080882A3 (en) 2002-04-04
AU2001257148B2 (en) 2006-03-30
JP4903342B2 (ja) 2012-03-28
DE60116280D1 (de) 2006-02-02
EP1274454A2 (en) 2003-01-15
DE60116280T2 (de) 2006-09-21
CA2406853A1 (en) 2001-11-01
ATE314088T1 (de) 2006-01-15
DK1274454T3 (da) 2006-05-15
WO2001080882A2 (en) 2001-11-01
JP2003534250A (ja) 2003-11-18
CA2406853C (en) 2012-06-26
EP1274454B1 (en) 2005-12-28

Similar Documents

Publication Publication Date Title
Cheng et al. Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system
TWI741241B (zh) 用於治療及/或預防異位性皮膚炎之il-31胜肽免疫原及其劑型
Matsushima et al. Thirty-five years since the discovery of chemotactic cytokines, interleukin-8 and MCAF: A historical overview
US20230285545A1 (en) Polypeptides, vaccine compositions, and use thereof for inducing immune response to sars-cov-2 in primates
KR100943825B1 (ko) 면역 반응을 강화하는 방법과 조성물
US20020071825A1 (en) Methods and compositions for inducing an immune response
ES2256232T3 (es) Metodos y composiciones para provocar una respuesta inmunitaria.
US20220105163A1 (en) Peptide immunogens targeting interleukin 6 (il-6) and formulations thereof for immunotherapy of diseases impacted by il-6 dysregulation
Boraschi et al. Interleukin-1 and interleukin-1 fragments as vaccine adjuvants
Dikopoulos et al. Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naive CD8+ T cells in the mouse
US7361329B2 (en) Compositions for inducing an immune response
AU2001257148A1 (en) Methods and compositions for eliciting an immune response
US8227569B2 (en) Immunomodulatory protein and useful embodiments thereof
WO2007042583A1 (es) Combinación inmunoe s t imuladora para profilaxis y tratamiento de hepatitis c
ES2225977T3 (es) Agonistas de interleuquina 4 selectivos para linfocitos t.
US8007776B2 (en) Vaccine composition comprising interleukin-15 (IL-15)
WO2003035106A1 (en) Methods and compositions for inducing an immune response by co-administering a chemokine with an antigen
WO2002085409A2 (en) Methods and compositions for inducing an immune response to an antigen
EP2112160B1 (en) Immunotherapeutic formulations to generate autoantibodies capable to avoid the binding of interleukin-2 to its receptor. Their use in the treatment of cancer
US20050234004A1 (en) Compositions and methods of use of W-peptides
TW200406219A (en) Agent elevating dentritic cell precursor level in blood
García et al. Factors that influence the immunogenicity of human recombinant interferon alpha-2b in mice
HK40025696A (en) Peptide immunogens of il-31 and formulations thereof for the treatment and/or prevention of atopic dermatitis